187 related articles for article (PubMed ID: 26187868)
41. A rare case of primary anaplastic large cell lymphoma of the central nervous system.
Kuntegowdenahalli LC; Jacob LA; Komaranchath AS; Amirtham U
J Cancer Res Ther; 2015; 11(4):943-5. PubMed ID: 26881551
[TBL] [Abstract][Full Text] [Related]
42. The oncogenic JUNB/CD30 axis contributes to cell cycle deregulation in ALK+ anaplastic large cell lymphoma.
Atsaves V; Lekakis L; Drakos E; Leventaki V; Ghaderi M; Baltatzis GE; Chioureas D; Jones D; Feretzaki M; Liakou C; Panayiotidis P; Gorgoulis V; Patsouris E; Medeiros LJ; Claret FX; Rassidakis GZ
Br J Haematol; 2014 Nov; 167(4):514-23. PubMed ID: 25145835
[TBL] [Abstract][Full Text] [Related]
43. [A case of primary central nervous system anaplastic lymphoma kinase positive anaplastic large cell lymphoma manifested as a unilateral pachymeningits].
Fujisawa E; Shibayama H; Mitobe F; Katada F; Sato S; Fukutake T
Rinsho Shinkeigaku; 2017 Nov; 57(11):705-710. PubMed ID: 29070753
[TBL] [Abstract][Full Text] [Related]
44. Primary anaplastic large cell lymphoma of the kidney.
Venizelos ID; Rombis V; Tulupidis S; Garipidou V
Leuk Lymphoma; 2003 Feb; 44(2):353-5. PubMed ID: 12688357
[TBL] [Abstract][Full Text] [Related]
45. Leukemic presentation of ALK-negative anaplastic large cell lymphoma in a patient with myelodysplastic syndrome.
Tanaka H; Ohwada C; Hashimoto S; Sakai S; Takeda Y; Abe D; Takagi T; Ohshima K; Nakaseko C
Intern Med; 2012; 51(2):199-203. PubMed ID: 22246491
[TBL] [Abstract][Full Text] [Related]
46. Small cell variant of anaplastic large cell lymphoma presenting as arm mass in a child: a rare entity with diagnostic challenge.
Pasricha S; Gandhi JS; Gupta G; Mehta A
J Cancer Res Ther; 2013; 9(2):317-9. PubMed ID: 23771387
[TBL] [Abstract][Full Text] [Related]
47. Anaplastic large cell lymphoma in a human immunodeficiency virus-positive patient with cytologic findings in bladder wash: a case report.
Proca DM; De Renne L; Marsh WL; Keyhani-Rofagha S
Acta Cytol; 2008; 52(1):83-6. PubMed ID: 18323280
[TBL] [Abstract][Full Text] [Related]
48. Brentuximab vedotin and crizotinib in anaplastic large-cell lymphoma.
Foyil KV; Bartlett NL
Cancer J; 2012; 18(5):450-6. PubMed ID: 23006951
[TBL] [Abstract][Full Text] [Related]
49. Cytomorphologic features of primary anaplastic large cell lymphoma of the psoas muscle: a case report and literature review.
Recavarren RA; Yang J
Diagn Cytopathol; 2010 Mar; 38(3):208-12. PubMed ID: 19760764
[TBL] [Abstract][Full Text] [Related]
50. Anaplastic large cell lymphoma, with 1,25(OH)
Mitobe M; Kawamoto K; Suzuki T; Kiryu M; Nanba A; Suwabe T; Tanaka T; Fuse K; Shibasaki Y; Masuko M; Miyoshi H; Ohshima K; Sone H; Takizawa J
J Clin Exp Hematop; 2019; 59(1):22-28. PubMed ID: 30918141
[TBL] [Abstract][Full Text] [Related]
51. Anaplastic large cell lymphoma: a single institution experience from India.
Lakshmaiah KC; Guruprasad B; Shah A; Kavitha S; Abraham LJ; Govindbabu K; Aruna Kumari BS; Appaji L
J Cancer Res Ther; 2013; 9(4):649-52. PubMed ID: 24518711
[TBL] [Abstract][Full Text] [Related]
52. Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas.
Dejean E; Renalier MH; Foisseau M; Agirre X; Joseph N; de Paiva GR; Al Saati T; Soulier J; Desjobert C; Lamant L; Prósper F; Felsher DW; Cavaillé J; Prats H; Delsol G; Giuriato S; Meggetto F
Leukemia; 2011 Dec; 25(12):1882-90. PubMed ID: 21778999
[TBL] [Abstract][Full Text] [Related]
53. Anaplastic large cell lymphoma involving the urinary bladder: a case report and review of the literature.
Chen H; Li Y; Nand S; Quek ML; Kini AR; Barkan GA
Diagn Cytopathol; 2015 Jan; 43(1):60-5. PubMed ID: 24623571
[TBL] [Abstract][Full Text] [Related]
54. [Anaplastic large-cell lymphoma CD30(+) ALK(+)].
Kollarikova L; Heizerova M; Simaljakova M
Hautarzt; 2016 Apr; 67(4):304-6. PubMed ID: 26620365
[TBL] [Abstract][Full Text] [Related]
55. Anaplastic large cell lymphoma in leukemic phase: extraordinarily high white blood cell count.
Nguyen JT; Condron MR; Nguyen ND; De J; Medeiros LJ; Padula A
Pathol Int; 2009 May; 59(5):345-53. PubMed ID: 19432678
[TBL] [Abstract][Full Text] [Related]
56. Leukemic phase of ALK(+) anaplastic large-cell lymphoma, small-cell variant: clinicopathologic pitfalls of a rare entity.
Ok CY; Wang SA; Amin HM
Clin Lymphoma Myeloma Leuk; 2014 Aug; 14(4):e123-6. PubMed ID: 24685107
[No Abstract] [Full Text] [Related]
57. Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous.
Xing X; Feldman AL
Adv Anat Pathol; 2015 Jan; 22(1):29-49. PubMed ID: 25461779
[TBL] [Abstract][Full Text] [Related]
58. Detection of a TRAF1-ALK fusion in an anaplastic large cell lymphoma patient with chemotherapy and ALK inhibitor-resistant disease.
Lawrence K; Berry B; Handshoe J; Hout D; Mazzola R; Morris SW; Saltman DL
BMC Res Notes; 2015 Jul; 8():308. PubMed ID: 26187744
[TBL] [Abstract][Full Text] [Related]
59. Primary cutaneous CD30 positive T-cell lymphoproliferative disorders with aberrant expression of PAX5: report of three cases.
Hagiwara M; Tomita A; Takata K; Shimoyama Y; Yoshino T; Tomita Y; Nakamura S
Pathol Int; 2012 Apr; 62(4):264-70. PubMed ID: 22449230
[TBL] [Abstract][Full Text] [Related]
60. Anaplastic large cell lymphoma: the most common T-cell lymphoma in pakistan.
Syed S; Khalil S; Pervez S
Asian Pac J Cancer Prev; 2011; 12(3):685-9. PubMed ID: 21627364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
